Skip to Content

Ondansetron Hydrochloride Injection

Last Updated: October 8, 2018
Status: Current

Products Affected - Description
    • Zofran injection, Novartis, 2 mg/mL, 20 mL vial, 1 count, NDC 00173-0442-00
    • Ondansetron injection, Apotex, 2 mg/mL, 2 mL vial, 25 count, NDC 60505-6130-05
    • Ondansetron injection, AuroMedics, 2 mg/mL, 2 mL vial, 25 count, NDC 55150-0125-02
    • Ondansetron injection, AuroMedics, 2 mg/mL, 20 mL vial, 1 count, NDC 55150-0126-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL prefilled syringe, 24 count, NDC 76045-0103-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 20 mL vial, 1 count, NDC 63323-0374-20
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 10 count, NDC 23155-0547-41
    • Ondansetron injection, Heritage, 2 mg/mL, 2 mL vial, 25 count, NDC 23155-0547-42
    • Ondansetron injection, Heritage, 2 mg/mL, 20 mL vial, 1 count, NDC 23155-0549-31
    • Ondansetron injection, Hikma, 2 mg/mL, 2 mL vial, 25 count, NDC 00641-6078-25
    • Ondansetron injection, Hikma, 2 mg/mL, 20 mL vial, 1 count, NDC 00143-9890-01
    • Ondansetron injection, Hikma, 2 mg/mL, 20 mL vial, 1 count, NDC 00641-6079-01
    • Ondansetron injection, Hikma, 2 mg/mL, 20 mL vial, 10 count, NDC 00143-9890-10
    • Ondansetron injection, Mylan Institutional, 2 mg/mL, 2 mL vial, 25 count, NDC 67457-0441-20
    • Ondansetron injection, Mylan Institutional, 2 mg/mL, 20 mL vial, 1 count, NDC 67457-0440-20
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL iSecure syringe, 10 count, NDC 00409-1120-12
    • Ondansetron injection, Pfizer, 2 mg/mL, 2 mL vial, 25 count, NDC 00409-4755-03
    • Ondansetron injection, Pfizer, 2 mg/mL, 20 mL vial, 1 count, NDC 00409-4759-01
    • Ondansetron injection, Sagent, 2 mg/mL, 2 mL vial, 25 count, NDC 25021-0777-02
    • Ondansetron injection, Sagent, 2 mg/mL, 20 mL vial, 1 count, NDC 25021-0782-20
Reason for the Shortage
    • Apotex did not provide a reason for the shortage.
    • Athenex had ondansetron injection on shortage due to increased demand.
    • AuroMedics did not provide a reason for the shortage.
    • Fresenius Kabi has ondansetron injection available.
    • Heritage has ondansetron on shortage due to increased demand.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional did not provide a reason for the shortage.
    • Pfizer has ondansetron injection on shortage due to manufacturing delays.
    • Sagent has ondansetron injection on shortage due to increased demand.
    • Novartis discontinued Zofran 20 mL vials in May 2018.
Available Products
    • Ondansetron injection, Athenex, 2 mg/mL, 2 mL vial, 25 count, NDC 70860-0776-02
    • Ondansetron injection, Athenex, 2 mg/mL, 20 mL vial, 1 count, NDC 70860-0777-20
    • Ondansetron injection, Fresenius Kabi, 2 mg/mL, 2 mL vial, 25 count, NDC 63323-0373-02

Estimated Resupply Dates

    • Apotex has ondansetron 2 mg/mL 2 mL vials on back order and the company cannot estimate a release date.
    • AuroMedics has ondansetron 2 mg/mL 2 mL and 20 mL vials on intermittent back order and the company is releasing product as it becomes available.
    • Fresenius Kabi has ondansetron 2 mg/mL 20 mL vials with a short-expiration date (<8 months). The 2 mg/mL 2 mg/mL 2 mL prefilled syringes are on back order and the company estimates a release date of late-October 2018.
    • Heritage has 2 mg/mL 2 mL vials on back order and the company estimates a release date in October 2018. The 20 mL vials are on allocation.
    • Hikma has ondansetron 2 mg/mL 20 mL vials in single count (NDC 00143-9890-01) and 10 count on back order and the company estimates a release date in mid- to late-October 2018. The 2 mg/mL 20 mL vials (NDC 00641-6079-01) are on back order and the company estimates a release date of October 2018. The 2 mg/mL 2 mL vials are on allocation.
    • Mylan Institutional has ondansetron 2 mg/mL 2 mL and 20 mL vials on back order and the company estimates a release date of late-October to early-November 2018 for the 2 mL vials and late-October 2018 for the 20 mL vials.
    • Pfizer has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of October 2018. The 2 mg/mL 20 mL vials are on back order and the company estimates a release date of November 2018. The 2 mg/mL 2 mL iSecure syringes are on back order and the company estimates a release date of 2019.
    • Sagent has ondansetron 2 mg/mL 2 mL vials on back order and the company estimates a release date of October 2018. The 2 mg/mL 20 mL vials are on back order and the company cannot estimate a release date.

Updated

Updated October 8, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide